Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Five Below
FIVE
$11.5B
| $20.6M | ﹤0.01% |
149,503
-91,723
| -38% | -$12M |
2016 Q3
24 quarters
|
|
1802
CALL
Zimmer Biomet
ZBH
$17.1B
| $20.5M | ﹤0.01% |
196,500
+67,500
| +52% | +$7.41M |
2013 Q2
37 quarters
|
|
1803
PUT
Alpha Metallurgical Resources
AMR
$2.25B
| $20.5M | ﹤0.01% |
149,900
+74,600
| +99% | +$10.4M |
2021 Q1
6 quarters
|
|
1804
ChargePoint
CHPT
$218M
| $20.5M | ﹤0.01% |
+69,481
| New | +$21.1M |
2022 Q3
0 quarters
|
|
1805
GlobalFoundries
GFS
$27.2B
| $20.4M | ﹤0.01% |
422,259
-2,250,740
| -84% | -$121M |
2021 Q4
3 quarters
|
|
1806
CALL
Monster Beverage
MNST
$85.7B
| $20.4M | ﹤0.01% |
938,800
-42,800
| -4% | -$986K |
2013 Q2
37 quarters
|
|
|
Y
1807
DELISTED
Alleghany Corp
Y
| $20.4M | ﹤0.01% |
24,307
+23,897
| +5,829% | +$20M |
2016 Q2
25 quarters
|
|
1808
Teva Pharmaceutical Industries Limited
TEVA
$48B
| $20.4M | ﹤0.01% |
2,526,757
-7,119,914
| -74% | -$63M |
2013 Q2
37 quarters
|
|
|
RXRA
1809
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $20.4M | ﹤0.01% |
2,071,848
+318
| +0% | +$3.13K |
2021 Q2
5 quarters
|
|
1810
PUT
Vale
VALE
$57.6B
| $20.4M | ﹤0.01% |
1,530,300
+683,900
| +81% | +$9M |
2016 Q2
25 quarters
|
|
1811
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $20.4M | ﹤0.01% |
168,026
+73,349
| +77% | +$9.45M |
2021 Q4
3 quarters
|
|
1812
PUT
Revolve Group
RVLV
$1.53B
| $20.3M | ﹤0.01% |
937,700
+8,600
| +0.9% | +$226K |
2019 Q3
12 quarters
|
|
1813
CALL
Steel Dynamics
STLD
$34.3B
| $20.3M | ﹤0.01% |
286,600
+19,300
| +7% | +$1.46M |
2013 Q2
37 quarters
|
|
|
STOR
1814
DELISTED
STORE Capital Corporation
STOR
| $20.3M | ﹤0.01% |
648,455
+487,893
| +304% | +$13.9M |
2014 Q4
31 quarters
|
|
|
1815
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48B
| $20.3M | ﹤0.01% |
2,510,800
-2,703,800
| -52% | -$23.9M |
2016 Q2
25 quarters
|
|
1816
Under Armour
UAA
$2.1B
| $20.2M | ﹤0.01% |
3,043,085
+2,318,523
| +320% | +$20.3M |
2015 Q3
28 quarters
|
|
1817
PUT
BioMarin Pharmaceuticals
BMRN
$10.8B
| $20.2M | ﹤0.01% |
238,700
-18,800
| -7% | -$1.67M |
2013 Q2
37 quarters
|
|
1818
Xometry
XMTR
$6.15B
| $20.2M | ﹤0.01% |
355,691
+220,979
| +164% | +$10.3M |
2021 Q2
5 quarters
|
|
|
CNR
1819
Core Natural Resources Inc
CNR
$4.44B
| $20.2M | ﹤0.01% |
313,661
-100,488
| -24% | -$6.36M |
2021 Q1
6 quarters
|
|
1820
Pan American Silver
PAAS
$19.3B
| $20.2M | ﹤0.01% |
1,270,133
+554,465
| +77% | +$9.66M |
2016 Q2
25 quarters
|
|
1821
Columbia Banking Systems
COLB
$8B
| $20.1M | ﹤0.01% |
696,417
+96,426
| +16% | +$2.91M |
2021 Q4
3 quarters
|
|
1822
PUT
M&T Bank
MTB
$31.3B
| $20.1M | ﹤0.01% |
113,900
-700
| -0.6% | -$124K |
2013 Q2
37 quarters
|
|
|
BPMC
1823
DELISTED
Blueprint Medicines
BPMC
| $20.1M | ﹤0.01% |
304,787
+235,528
| +340% | +$15.1M |
2021 Q2
5 quarters
|
|
|
SJIV
1824
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
| $20.1M | ﹤0.01% |
300,827
+235
| +0.1% | +$16K |
2021 Q1
6 quarters
|
|
1825
PUT
BHP
BHP
$218B
| $20.1M | ﹤0.01% |
401,300
-166,300
| -29% | -$8.81M |
2016 Q2
25 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.